Grandiflora-mediated ZnO-NPs have good potential in the anti- TNBC therapy, in nanobiotechnology for cancer treatment, so further research is needed for the development of potential drug formulation to treat TNBC.
Kavithaa Krishnamoorthy, Santhoshkumar Ravichandran, Senthilkumar Palanisamy et al.· Journal of Drug Delivery and...· 0 citations
The interleukin-1 receptor antagonist (IL-1Ra) is a key anti-inflammatory cytokine that inhibits interleukin-1 signaling by competitively binding to IL-1 receptors. However, recombinant IL-1Ra, currently produced in Escherichia coli, exhibits limited pharmacokinetics and requires frequent administration due to its sh...
Anith Kumar Rajendran, Vaishnavi Ashokkumar, T. Krishnaraj et al.· ACS Synthetic Biology· 0 citations
The integration of nanobiotechnology with precision medicine holds promise for more tailored, adaptive, and patient-oriented approaches to cancer care as well as emergent trends such as AI-assisted design of nanoparticles, patient-specific nanotherapeutics, optogenetic strategies and sustainable green synthesis.
Kavithaa Krishnamoorthy, Sabarinathan Ramalingam, Senthilkumar Palanisamy et al.· Journal of Biomedicine and B...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.